Advertisement
Journal Home
Search for

Volume 38, Issue 17, Page 31 (1 September 2008)


View previous. 38 of 83 View next.

Congenital Malformation Risk Rose With Use of Topiramate

MICHELE G. SULLIVAN (Mid-Atlantic Bureau)

Topiramate is associated with a significantly increased risk of major congenital malformations, whether given as monotherapy or as part of a polytherapy antiepileptic regimen, Dr. Stephen Hunt and his colleagues have reported.

PII: S0300-7073(08)71106-X

doi:10.1016/S0300-7073(08)71106-X


View previous. 38 of 83 View next.